Top Purchase Related
Home
>
Node
>
Subnode

Zidovudine treatment and virus excretion in the cervicovaginal secretions of HIV-infected women

Nicolosi, A.

Journal of Acquired Immune Deficiency Syndromes 6(7): 852-854

1993

ISSN/ISBN: 0894-9255
PMID: 8509988
Document Number: 410949

Document emailed within 1 workday
Secure & encrypted payments

Lu, X.S.; Bélec, L.; Pillot, J. 1993: Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women Journal of Infectious Diseases 167(5): 1189-1192
Rasheed, S.; Li, Z.; Xu, D.; Kovacs, A. 1996: Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women American Journal of Obstetrics and Gynecology 175(1): 122-129
Anderson, D.; Johnson, P.M. 1994: Cervicovaginal virus secretion in HIV-infected women Journal of Acquired Immune Deficiency Syndromes 7(2): 204
Zijenah, L.S.; Kadzirange, G.; Rusakaniko, S.; Kufa, T.; Gonah, N.; Tobaiwa, O.; Gwanzura, C.; Matsikire, E.; Katzenstein, D.A. 2006: A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe Central African Journal of Medicine 52(1-2): 1-8
Lertcheewakarn, P.; Tongprasert, F. 2014: A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 97(4): 361-368
Mays, D.C.; Dixon, K.F.; Balboa, A.; Pawluk, L.J.; Bauer, M.R.; Nawoot, S.; Gerber, N. 1991: A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats Journal of Pharmacology and Experimental Therapeutics 259(3): 1261-1270
Todd, J.; Riedner, G.; Maboko, L.; Hoelscher, M.; Weiss, H.A.; Lyamuya, E.; Mabey, D.; Rusizoka, M.; Belec, L.; Hayes, R. 2013: Effect of Genital Herpes on Cervicovaginal HIV Shedding in Women Co-Infected with HIV and Hsv-2 in Tanzania Plos one 8(3): E59037
Seck, K.; Samb, N.; Tempesta, S.; Mulanga-Kabeya, C.; Henzel, D.; Sow, P.S.; Coll-Seck, A.; Mboup, S.; Ndoye, I.; Delaporte, E. 2001: Prevalence and risk factors of cervicovaginal HIV shedding among HIV-1 and HIV-2 infected women in Dakar, Senegal Sexually Transmitted Infections 77(3): 190-193
Péc, J.; Moravcík, P.; Lazarová, Z. 1994: Quantification of Neisseria gonorrhoeae from the cervicovaginal area in nonpregnant women infected with gonorrhoea Bratislavske Lekarske Listy 95(3): 122-124
Robiner, W.N.; Melroe, N.H.; Campbell, S.; Rhame, F.S.; Colón, E.; Chung, J.; Reaney, S. 1993: Psychological effects of participation and nonparticipation in a placebo-controlled zidovudine clinical trial with asymptomatic human immunodeficiency virus-infected individuals Journal of Acquired Immune Deficiency Syndromes 6(7): 795-808
Staszewski, S.; Keiser, P.; Montaner, J.; Raffi, F.; Gathe, J.; Brotas, V.; Hicks, C.; Hammer, S.M.; Cooper, D.; Johnson, M.; Tortell, S.; Cutrell, A.; Thorborn, D.; Isaacs, R.; Hetherington, S.; Steel, H.; Spreen, W. 2001: Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial JAMA 285(9): 1155-1163
Briand, N.; Le Coeur, S.; Jourdain, G.; Hotrawarikarn, S.; Sirinontakan, S.; Hinjiranandana, T.; Kanjanavanit, S.; Traisathit, P.; McIntosh, K.; Lallemant, M.; Weerawatgoompa, S.L.; Karnchanamayul, V.; Tantiyaworawongse, C.; Ariyadej, S.; Hansudewechakul, R.; Achalapong, J.; Srismith, R.; Wattanaporn, P.; Phongpanich, S.; Yuthavisuthi, P.; Ngampiyasakul, C.; Sooksengchai, S.; Bhakeecheep, S.; Hemvuttiphan, J.; Thambhitak, L.; Lattiwongsakorn, V.; Ithisukanan, J.; Siritathandon, S.; Boonrod, K.; Piyaman, S.; Pinchan, P.; Chotivanich, N.; Hongsiriwon, S.; Kittikoon, P.; Prommat, S.; Nimkarn, S.; Charnivises, S.; Suraseranivong, V.; Layangool, P.; Gulakirt, B.; Putiyanun, C.; Limsuwan, S.; Charkrit, S.; Sirichai, H.; Jindaapilukkul, P.; Kunkon 2010: Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in Thailand Aids Research and Human Retroviruses 26(10): 1163-1166
Pugliese, A.; Saini, A.; Andronico, L.; Pagliano, G.; Gallo, G. 2001: Sexually transmitted infections and cervicovaginal dysplasia in a cohort of human immunodeficiency virus-positive women in Turin Cancer Detection and Prevention 25(1): 32-39
Gartland, M. 2001: AVANTi 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients Antiviral Therapy 6(2): 127-134
Wofsy, C.B.; Cohen, J.B.; Hauer, L.B.; Padian, N.S.; Michaelis, B.A.; Evans, L.A.; Levy, J.A. 1986: Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus Lancet 1(8480): 527-529
Sachdeva, R.K.; Wanchu, A.; Bagga, R.; Malla, N.; Sharma, M. 2010: Effect of non-nucleoside reverse transcriptase inhibitors on cytokine, chemokine, and immunoglobulin profiles in serum and genital secretions of HIV-infected women Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 30(5): 299-310
Goodgame, J.C.; Pottage, J.C.; Jablonowski, H.; Hardy, W.D.; Stein, A.; Fischl, M.; Morrow, P.; Feinberg, J.; Brothers, C.H.; Vafidis, I.; Nacci, P.; Yeo, J.; Pedneault, L. 2000: Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team Antiviral Therapy 5(3): 215-225
Moolasart, P.; Likanonsakul, S. 2002: The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children Southeast Asian Journal of Tropical Medicine and Public Health 33(2): 280-287
Kaplan, A.S.; Erickson, J.S.; Ben-Porat, T. 1975: Excretion of specific glycoproteins by cells infected with herpes simplex virus, types 1 and 2 Progress in Medical Virology. Fortschritte der Medizinischen Virusforschung. Progres en Virologie Medicale 21: 1-12
Chasela, C.S.; Wall, P.; Drobeniuc, J.; King, C.C.; Teshale, E.; Hosseinipour, M.C.; Ellington, S.R.; Codd, M.; Jamieson, D.J.; Knight, R.J.; Fitzpatrick, P.; Kourtis, A.P.; Hoffman, I.F.; Kayira, D.; Mumba, N.; Kamwendo, D.D.; Martinson, F.; Powderly, W.; van der Horst, C.; Kamili, S.; Adair, L.; Ahmed, Y.; Ait-Khaled, M.; Albrecht, S.; Bangdiwala, S.; Bayer, R.; Bentley, M.; Bramson, B.; Bobrow, E.; Boyle, N.; Butera, S.; Chasela, C.; Chavula, C.; Chimerang'ambe, J.; Chigwenembe, M.; Chikasema, M.; Chikhungu, N.; Chilongozi, D.; Chiudzu, G.; Chome, L.; Cole, A.; Corbett, A.; Corneli, A.; Dow, A.; Duerr, A.; Eliya, H.; Ellington, S.; Eron, J.; Farr, S.; Ferguson, Y.O.; Fiscus, S.; Flax, V.; Fokar, A.; Galvin, S.; Guay, L.; Heilig, C.; Hoff 2012: Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 54(4): 318-320